CCNE1 and esophageal cancer: Expectedly, TP53 was decreased (Figure 6A, arrows), whereas cyclin E was increased (Figures 6B, 6C, arrows) when exposed to CDDP in esophageal cancer cell lines (TE2 and TE1 with benign TP53 variation).